Showing 1281-1290 of 5603 results for "".
Moving Beyond Correction: WCO’s Standard of Care for Myopia Management
https://reachmd.com/programs/eye-on-ocular-health/moving-beyond-correction-wcos-standard-of-care-for-myopia-management/36284/Myopia is more than blurred vision; it's a chronic condition requiring lifelong attention that could affect up to five billion people by 2050. In response to this growing crisis, the World Council of Optometry (WCO) has issued standard-of-care guidelines built around three pillars: Mitigation, MeasuA Personalized Approach to Uncontrolled Asthma Management
https://reachmd.com/programs/on-the-frontlines-of-asthma/personalized-management-uncontrolled-asthma/56829/Despite significant advances in treatment, many patients with asthma continue to experience uncontrolled symptoms driven by gaps in diagnosis, treatment optimization, inhaler technique, environmental exposures, and underlying comorbidities. Join Dr. Steve Jackson and Dr. Sujith V. Cherian as they exNeed to Grow Your Clinical Practice? Create an App for That!
https://reachmd.com/programs/your-career-in-healthcare/need-to-grow-your-clinical-practice-create-an-app-for-that/6977/As a busy health professional doing what you love, you still need to think about how to grow your business. How do you balance the clinical and business-related demands? Host Tim Rush welcomes Michael Weber, MD, cardiologist and entreprenuer, who shares his story about developing a new medical app tCDC - Sodium Reduction: Time for Choice, Part 3
https://reachmd.com/programs/grand-rounds-nation/cdc-sodium-reduction-time-for-choice-part-3/6439/The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, butPreventing A Million Heart Attacks and Strokes: A Turning Point for Impact
https://reachmd.com/programs/grand-rounds-nation/preventing-a-million-heart-attacks-and-strokes-a-turning-point-for-impact/7246/Heart attacks and strokes contribute to the almost 800,000 deaths from cardiovascular disease each year. The trauma to families and communities is devastating; the cost to the US economy is nearly $1 billion each day in medical costs and lost productivity. To achieve sustainable prevention, the DepaCDC - Sodium Reduction: Time for Choice, Part 2
https://reachmd.com/programs/grand-rounds-nation/cdc-sodium-reduction-time-for-choice-part-2/6438/The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, butCDC - Sodium Reduction: Time for Choice, Part 1
https://reachmd.com/programs/grand-rounds-nation/cdc-sodium-reduction-time-for-choice-part-1/6437/The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, butCombination Therapy for Plaque Psoriasis: A Reappraisal of Cyclosporine and Acitretin
https://reachmd.com/programs/dermconsult/combination-therapy-for-plaque-psoriasis-a-reappraisal-of-cyclosporine-and-acitretin/32813/Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
https://reachmd.com/programs/cme/modern-obstructive-hcm-care-from-unmet-needs-to-individualized-myosin-inhibitor-therapy/54306/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
https://reachmd.com/programs/cme/when-gdmt-isnt-enough-understanding-residual-risk-in-patients-with-hfref/51036/Drs. Bauersachs, Butler & Lam discuss persistent residual risk in HFrEF, the use of sGC stimulators to reduce risk, and supporting evidence for this approach.